Your browser doesn't support javascript.
loading
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials.
Kohrt, Holbrook E; Tumeh, Paul C; Benson, Don; Bhardwaj, Nina; Brody, Joshua; Formenti, Silvia; Fox, Bernard A; Galon, Jerome; June, Carl H; Kalos, Michael; Kirsch, Ilan; Kleen, Thomas; Kroemer, Guido; Lanier, Lewis; Levy, Ron; Lyerly, H Kim; Maecker, Holden; Marabelle, Aurelien; Melenhorst, Jos; Miller, Jeffrey; Melero, Ignacio; Odunsi, Kunle; Palucka, Karolina; Peoples, George; Ribas, Antoni; Robins, Harlan; Robinson, William; Serafini, Tito; Sondel, Paul; Vivier, Eric; Weber, Jeff; Wolchok, Jedd; Zitvogel, Laurence; Disis, Mary L; Cheever, Martin A.
Afiliación
  • Kohrt HE; Division of Oncology, Stanford Cancer Institute, Stanford University Medical Center, 269 Campus Drive, CCSR 1105, Stanford, CA 94305-5151 USA.
  • Tumeh PC; Division of Dermatology, Department of Medicine, University of California Los Angeles, Los Angeles, CA USA.
  • Benson D; Division of Hematology/Oncology, Ohio State University, Columbus, OH USA.
  • Bhardwaj N; Medicine, Hematology and Medical Oncology, Mount Sinai Hospital, New York, NY USA.
  • Brody J; Medicine, Hematology and Medical Oncology, Mount Sinai Hospital, Ruttenberg Treatment Center, New York, NY USA.
  • Formenti S; Department of Radiation Oncology, New York Weill Cornell Medical Center, New York, NY USA.
  • Fox BA; SOM-Molecular Microbiology & Immunology Department, Laboratory of Molecular and Tumor Immunology, OHSU Cancer Institute, Portland, OR USA.
  • Galon J; INSERM, Integrative Cancer Immunology Team, Cordeliers Research Center, Paris, France.
  • June CH; Perelman School of Medicine, University of Pennsylvania, Pathology and Laboratory Medicine, Philadelphia, PA USA.
  • Kalos M; Cancer Immunobiology, Eli Lilly & Company, New York, NY USA.
  • Kirsch I; Translational Medicine, Adaptive Biotechnologies Corp, Seattle, WA USA.
  • Kleen T; Immune Monitoring, Epiontis GmbH, Berlin, Germany.
  • Kroemer G; Faculty of Medicine, University of Paris Descartes, Paris, France.
  • Lanier L; Department of Microbiology and Immunology, University of California, San Francisco, CA USA.
  • Levy R; Division of Oncology, Stanford School of Medicine, Stanford, CA USA.
  • Lyerly HK; Duke University School of Medicine, Durham, NC USA.
  • Maecker H; Human Immune Monitoring Center Shared Resource, Stanford Cancer Institute, Stanford, CA USA.
  • Marabelle A; Léon Bérard Cancer Center, Lyon, France.
  • Melenhorst J; Product Development and Correlative Sciences, Smilow Center for Translational Research, Philadelphia, PA USA.
  • Miller J; Division of Hematology, Experimental Therapeutics, University of Minnesota, Oncology and Transplantation, Minneapolis, MN USA.
  • Melero I; Centro de Investigacion Medica Aplicada, Universidad de Navarra, Avda. Pamplona, Spain.
  • Odunsi K; Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY USA.
  • Palucka K; Baylor Institute for Immunology Research, Dallas, TX USA.
  • Peoples G; Cancer Vaccine Development Program, Brooke Army Medical Center, Houston, TX USA.
  • Ribas A; Tumor Immunology Program Area, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA USA.
  • Robins H; Adaptive Biotechnologies, Seattle, WA USA.
  • Robinson W; Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA USA.
  • Serafini T; Atreca, Inc, Redwood City, CA USA.
  • Sondel P; Cellular & Molecular Pathology Graduate Program, University of Wisconsin-Madison, Madison, WI USA.
  • Vivier E; Centre d'Immunologie de Marseille-Luminy, Marseille, France.
  • Weber J; Moffitt Cancer Center, Tampa, FL USA.
  • Wolchok J; Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY USA.
  • Zitvogel L; Institut National de la Santé et Recherche Médicale, Institut GrustaveRoussy, Villejuif, France.
  • Disis ML; Tumor Vaccine Group, University of Washington, Seattle, WA USA.
  • Cheever MA; Fred Hutchinson Cancer Research Center, 1100 Eastlake Ave N., E3-300, PO Box 19024, Seattle, WA 98109-1023 USA.
J Immunother Cancer ; 4: 15, 2016.
Article en En | MEDLINE | ID: mdl-26981245

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Immunother Cancer Año: 2016 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Immunother Cancer Año: 2016 Tipo del documento: Article